Action Pharmadrug - BUZZ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,06

Prix Achat

0,06

Prix Vente

0,065

Volume échangé

0,00 Fourchette du Jour 0,00

0,06 Plage de 52 semaines 0,06

Clôture Veille

0,06

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS...

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT...

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY Toronto...

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE Toronto, Ontario--(Newsfile Corp. - February 11, 2021) - PharmaDrug Inc. (CSE:...

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD FOR PSYCHEDELIC...

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND Provides update on german operations and balance sheet improvements...

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC. Toronto, Ontario -- February 2, 2021 -- InvestorsHub...

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC. WHO RECENTLY RECEIVED ORPHAN DRUG DESIGNATION FROM FDA FOR...

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC. Toronto, Ontario -- January 12, 2021 -- InvestorsHub...

Aura Announces Pharmadrug Operational & Investor Relations Update

TORONTO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ, OTCQB:LMLLF...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.06	0.06	0.06	0	0	CS
4	0	0	0.06	0.06	0.06	0	0	CS
12	0	0	0.06	0.06	0.06	0	0	CS
26	0	0	0.06	0.06	0.06	0	0	CS
52	0	0	0.06	0.06	0.06	0	0	CS
156	0	0	0.06	0.06	0.06	0	0	CS
260	0.03	100	0.03	0.205	0.01	914448	0.0908247	CS

BUZZ - Frequently Asked Questions (FAQ)

What is the current Pharmadrug share price?

The current share price of Pharmadrug is $ 0,06

What is the 1 year trading range for Pharmadrug share price?

Pharmadrug has traded in the range of $ 0,06 to $ 0,06 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
CVGRCity View Green Holdings Inc	$ 0,015 (200,00%)	3,98M
SQXSquatex Energy and Ressources Inc	$ 0,015 (200,00%)	73k
IANiAnthus Capital Holdings Inc	$ 0,01 (100,00%)	28,55k
PPBP2P Group Ltd	$ 0,23 (70,37%)	984,98k
CCCCarlyle Commodities Corp	$ 0,025 (66,67%)	37,52k
WBIOWPD Pharmaceuticals Inc	$ 0,07 (-63,16%)	8k
EOMEco Oro Minerals Corp	$ 0,01 (-60,00%)	139k
STKTStickIt Technologies Inc	$ 0,005 (-50,00%)	13k
FNQFineqia International Inc	$ 0,005 (-50,00%)	202,99k
GMRGelum Resources Ltd	$ 0,015 (-40,00%)	4,5k
CVGRCity View Green Holdings Inc	$ 0,015 (200,00%)	3,98M
QIMCQuebec Innovative Materials Corp	$ 0,21 (-23,64%)	3,79M
SOLSOL Global Investments Corp	$ 0,27 (-3,57%)	2,75M
PUMPStock Trend Capital Inc	$ 0,015 (0,00%)	2,33M
CACRKWG Resources Inc	$ 0,02 (33,33%)	1,36M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmadrug Inc (BUZZ)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

BUZZ Dernières nouvelles

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC

Aura Announces Pharmadrug Operational & Investor Relations Update

BUZZ - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Pharmadrug Inc (BUZZ) Cours

Pharmadrug Inc (BUZZ)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

BUZZ Dernières nouvelles

PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES

PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY

PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE

PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont

PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS

PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.

PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC

Aura Announces Pharmadrug Operational & Investor Relations Update

BUZZ - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités